SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceutical Co. Ltd. Announce Filing of Supplemental New Drug Application for AMITIZA (Lubiprostone) in Opioid-induced Constipation